![]() |
Volumn 132, Issue 39, 2010, Pages 13663-13665
|
Benzothiazinones: Prodrugs that covalently modify the decaprenylphosphoryl- β-D-ribose 2′-epimerase DprE1 of mycobacterium tuberculosis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACTIVE SITE;
ANTI-MYCOBACTERIAL;
CYSTEINE RESIDUES;
D-RIBOSE;
MECHANISM OF ACTION;
MYCOBACTERIUM TUBERCULOSIS;
NITRO GROUP;
NITROSO;
PRODRUGS;
ANTIMYCOBACTERIAL AGENT;
BENZOTHIAZINE DERIVATIVE;
CYSTEINE;
DECAPRENYLPHOSPHORYL BETA DEXTRO RIBOSE 2' EPIMERASE;
EPIMERASE;
NITRO DERIVATIVE;
NITROSO DERIVATIVE;
PRODRUG;
UNCLASSIFIED DRUG;
ANTIBACTERIAL ACTIVITY;
ARTICLE;
CHEMICAL MODIFICATION;
COVALENT BOND;
DRUG MECHANISM;
DRUG POTENCY;
DRUG TARGETING;
ENZYME ACTIVE SITE;
MYCOBACTERIUM BOVIS;
MYCOBACTERIUM SMEGMATIS;
MYCOBACTERIUM TUBERCULOSIS;
NONHUMAN;
ANTI-BACTERIAL AGENTS;
CATALYTIC DOMAIN;
MOLECULAR CONFORMATION;
MYCOBACTERIUM TUBERCULOSIS;
PRODRUGS;
RACEMASES AND EPIMERASES;
STEREOISOMERISM;
STRUCTURE-ACTIVITY RELATIONSHIP;
THIAZINES;
|
EID: 77957310736
PISSN: 00027863
EISSN: 15205126
Source Type: Journal
DOI: 10.1021/ja106357w Document Type: Article |
Times cited : (190)
|
References (17)
|